Bcl-xL Genetic Modification Enhanced the Therapeutic Efficacy of Mesenchymal Stem Cell Transplantation in the Treatment of Heart Infarction.
about
Combined administration of mesenchymal stem cells overexpressing IGF-1 and HGF enhances neovascularization but moderately improves cardiac regeneration in a porcine model.Can the outcomes of mesenchymal stem cell-based therapy for myocardial infarction be improved? Providing weapons and armour to cells.Neural differentiation of human Wharton's jelly-derived mesenchymal stem cells improves the recovery of neurological function after transplantation in ischemic stroke ratsConcise Review: Rational Use of Mesenchymal Stem Cells in the Treatment of Ischemic Heart Disease.Recent Progress in Stem Cell Modification for Cardiac Regeneration.Data on long noncoding RNA upregulated in hypothermia treated cardiomyocytes protects against myocardial infarction through improving mitochondrial function.
P2860
Bcl-xL Genetic Modification Enhanced the Therapeutic Efficacy of Mesenchymal Stem Cell Transplantation in the Treatment of Heart Infarction.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Bcl-xL Genetic Modification En ...... Treatment of Heart Infarction.
@ast
Bcl-xL Genetic Modification En ...... Treatment of Heart Infarction.
@en
type
label
Bcl-xL Genetic Modification En ...... Treatment of Heart Infarction.
@ast
Bcl-xL Genetic Modification En ...... Treatment of Heart Infarction.
@en
prefLabel
Bcl-xL Genetic Modification En ...... Treatment of Heart Infarction.
@ast
Bcl-xL Genetic Modification En ...... Treatment of Heart Infarction.
@en
P2093
P2860
P356
P1476
Bcl-xL Genetic Modification En ...... Treatment of Heart Infarction.
@en
P2093
P2860
P304
P356
10.1155/2015/176409
P50
P577
2015-05-05T00:00:00Z